Navigation Links
PDL Settles Litigation and Resolves Other Disputes
Date:2/28/2011

INCLINE VILLAGE, Nev., Feb. 28, 2011 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that it has entered into a definitive settlement agreement with Novartis that resolves all disputes between them.  Under the settlement agreement, PDL agreed to dismiss its claims against Novartis in its action in Nevada court, which also includes Genentech, Inc. (Genentech) and F. Hoffmann-La Roche Ltd (Roche) as defendants. Novartis agreed to withdraw its opposition appeal in the European Patent Office challenging the validity of PDL's Queen patent in Europe. In addition, PDL agreed to pay Novartis certain amounts based on net sales of Lucentis made by Novartis during calendar year 2011 and beyond.

The settlement with Novartis does not affect PDL's claims against Genentech and Roche in the Nevada state court action.

About PDL BioPharma

PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. PDL is focused on maximizing the value of its antibody humanization patents and related assets. The Company receives royalties on sales of a number of humanized antibody products marketed by leading pharmaceutical and biotechnology companies today based on patents which expire in late 2014. For more information, please visit www.pdl.com.

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

Forward Looking Statement

This press release contains forward-looking statements. Each of these forward-looking statements involves risks and uncertainties. Actual results may differ materially from those, express or implied, in these forward-looking statements, including, for example, if Novartis or PDL fail to timely fulfill
'/>"/>

SOURCE PDL BioPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
2. Northwest Biotherapeutics Settles Class Action Complaint, and SEC Investigation Closed Without Action
3. Celsis IVT Settles LiverPool Patent Infringement Suit With XenoTech, LLC
4. Neuralstem, Inc. Settles Litigation Against ReNeuron, Ltd.
5. Viral Genetics Settles Litigation and Reacquires African Rights for HIV/AIDS Products
6. Milestone Scientific Acquires Additional Patent Rights for Painless Injections and Resolves Related Litigations
7. Occlutech Obtains Favourable Court Ruling in Patent Litigation in The Hague Against AGA Medical
8. Boston Scientific Resolves Outstanding Litigation Matter, Finalizes Goodwill Impairment Charge
9. OmniComm Systems Announces Settlement of Patent Litigation With DataSci, LLC
10. Endocare and Galil Medical Announce Settlement of Litigation
11. Eli Lilly & Company and ScinoPharm Taiwan Ltd. Announce Settlement of Gemcitabine Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... new study by researchers from the University of ... nanosystems function, unlocking the potential to create new ... which has been published in the prestigious academic ... novel laser technique to examine in rich detail ... small cluster containing an acetylene molecule and a ...
(Date:7/25/2014)... Pittsburgh, PA (PRWEB) July 25, 2014 ... annual Call for Topics for Conferee Networking. These two-hour ... similar interests to meet and resolve problems, discuss new ... , The deadline to submit a topic for consideration ... at pittcon.org . The Conferee Networking committee will ...
(Date:7/25/2014)... Muncie, IN (PRWEB) July 25, 2014 ... Administration (FAA) has granted a 60-day extension for the ... of the Special Rule for Model Aircraft established by ... Act of 2012. The 60-day extension establishes the new ... the United States Department of Transportation/FAA notice published in ...
(Date:7/24/2014)... Gain recognition for leadership and contribution ... biotech industry. Nominations are now being accepted for ... by the Bio Supply Management Alliance , ... professionals for the past 7 years. , Awards ... industry – Manufacturers, Service Providers, Material Suppliers, Technology ...
Breaking Biology Technology:Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 3Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2FAA Grants Comment Extension at the Request of AMA 2Call for Submission: BSMA’s Supply Chain Management Innovation Awards 2Call for Submission: BSMA’s Supply Chain Management Innovation Awards 3
... Shire plc (LSE: SHP, NASDAQ: SHPGY ), ... Barr Laboratories, Inc.,("Barr) and Mylan, Inc. ("Mylan) dated 2 ... the filing of an Abbreviated New Drug Application,("ANDA") for ... carbonate). , FOSRENOL is protected ...
... MTA: CTIC) management,s presentation at the 11th Annual BIO CEO &,Investor Conference on ... http://www.celltherapeutics.com . , The presentation will take place ... replay after the presentation. , , ... BIO CEO & Investor Conference, ...
... Cancer Clinics of Excellence, LLC, the nation,s ... completion of its 62nd comprehensive Evidence-Based Treatment Protocol ... at the 4th Annual Community Oncology Conference today. ... fully prepared to launch the protocols across its ...
Cached Biology Technology:Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan 2Cancer Clinics of Excellence (CCE) Releases 62nd Evidence-Based Treatment Protocol 2
(Date:7/24/2014)... which have similar counterparts in humans, affect the connections ... signals into the hippocampus, an area of the brain ... the creation of memories. The results of the study ... , Brain function depends on the active communication between ... are woven together into a dense network where they ...
(Date:7/24/2014)... a hotspot of biodiversity and one of the most ... in the world. However, current levels of diversity might ... been an increase in the description of new endemic ... molecular techniques and availability of samples for DNA analysis. ... for molecular and morphological analysis, researchers from the ...
(Date:7/24/2014)... For years, researchers and patients have hoped that ... type in the bodycould provide insight into numerous diseases ... has been hampered by the inability to transfer research ... counterparts, in part because human ESCs are "primed" and ... Thorold Theunissen, Benjamin Powell, and Haoyi Wang, who are ...
Breaking Biology News(10 mins):A protein couple controls flow of information into the brain's memory center 2A protein couple controls flow of information into the brain's memory center 3A protein couple controls flow of information into the brain's memory center 4A tiny new species of frog from Brazil with a heroic name 2Whitehead Institute researchers create 'naïve' pluripotent human embryonic stem cells 2
... technology that makes it possible to zoom in on ... at Dana-Farber Cancer Institute have identified nearly 100 chromosome ... non-small cell lung cancer. The findings provide new clues ... most common type of lung cancer –?and one of ...
... water quality, creation of coastal "dead zones," the collapse ... some of the potential consequences of humankind's degradation of ... report launched today. , Humans have changed ecosystems more ... in any other period, some 60 per cent of ...
... of molecular signals that instructs cells with fatally damaged DNA ... p53 is inactivated, as it is in over half of ... to operate, and body cells start to accumulate mutations, which ... this vital safeguard has been studied in great detail for ...
Cached Biology News:High-powered gene profiles provide clues to genes involved in common form of lung cancer 2High-powered gene profiles provide clues to genes involved in common form of lung cancer 3UN: World in big ecological mess 2UN: World in big ecological mess 3Cancer related gene p53 not regulated as indicated by previous tissue culture research 2Cancer related gene p53 not regulated as indicated by previous tissue culture research 3
This is a PYREX replacement Allihn condenser with a 34/45 inner joint on the bottom for the No. CLS3840-S 125mL extractor system. The tubulation O.D. on the condenser is 10mm....
... unique human proteins on a 1x3 ... a cross section of all cellular ... high-quality results. Additional control proteins and ... validity and reproducibility., ,UNIchip protein microarrays ...
... unique human proteins on a 1x3 ... all intracellular proteins (IP) according to ... quadruplicate for high-quality results. Additional control ... guarantee high validity and reproducibility., UNIchip ...
...
Biology Products: